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Abstract
Long noncoding RNAs (lncRNAs) can regulate target gene expres-
sion by acting in cis (locally) or in trans (non-locally). Here, we
performed genome-wide expression analysis of Toll-like receptor
(TLR)-stimulated human macrophages to identify pairs of cis-
acting lncRNAs and protein-coding genes involved in innate immu-
nity. A total of 229 gene pairs were identified, many of which were
commonly regulated by signaling through multiple TLRs and were
involved in the cytokine responses to infection by group B Strepto-
coccus. We focused on elucidating the function of one lncRNA,
named lnc-MARCKS or ROCKI (Regulator of Cytokines and
Inflammation), which was induced by multiple TLR stimuli and
acted as a master regulator of inflammatory responses. ROCKI
interacted with APEX1 (apurinic/apyrimidinic endodeoxyribonucle-
ase 1) to form a ribonucleoprotein complex at the MARCKS
promoter. In turn, ROCKI–APEX1 recruited the histone deacetylase
HDAC1, which removed the H3K27ac modification from the
promoter, thus reducing MARCKS transcription and subsequent
Ca2+ signaling and inflammatory gene expression. Finally, genetic
variants affecting ROCKI expression were linked to a reduced risk
of certain inflammatory and infectious disease in humans, includ-
ing inflammatory bowel disease and tuberculosis. Collectively,
these data highlight the importance of cis-acting lncRNAs in TLR
signaling, innate immunity, and pathophysiological inflammation.
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Introduction
To date, approximately 16,000 human and 12,000 mouse genes for
long noncoding RNAs (lncRNAs; defined as > 200 nucleotides)
have been identified, making them the largest known class of
noncoding RNAs in the mammalian genome GENCODE (https://
www.gencodegenes.org). lncRNAs are versatile regulators of gene
expression that interact with DNA, RNA, and proteins, and function
through multiple diverse mechanisms that include acting as scaf-
folds, decoys, and recruiters of genetic modifiers (Cech & Steitz,
2014; Quinn & Chang, 2016; Kopp & Mendell, 2018). Of particular
interest, although lncRNAs are able to regulate the expression of
neighboring genes (acting in cis) and/in distantly located genes (in
trans), increasing evidence suggests that the majority act in cis
(Guil & Esteller, 2012). Functional classification of lncRNAs is
important for developing experimental approaches to understand
lncRNA functions (Kopp & Mendell, 2018).
Innate immunity is a fundamental component of anti-pathogen
defense in eukaryotes and is mediated by several families of cell
surface and intracellular pattern recognition receptors, including
Toll-like receptors (TLRs), C-type lectin receptors, RIG-I-like
receptors, NOD-like receptors, and AIM2-like receptors
(Mogensen, 2009). The innate immune system acts as a sensor of
microbial infections to rapidly activate defense responses and to
initiate long-lasting adaptive immunity (Iwasaki & Medzhitov,
2015). The human genome encodes about 10 TLR genes, each
specialized in recognizing highly conserved structural motifs
produced by microbial pathogens (pathogen-associated microbial
patterns, PAMPs) (Song & Lee, 2012). TLRs can function as
homodimers or heterodimers; for example, TLR2/TLR1 and TLR2/
TLR6 heterodimers recognize lipopeptides from bacteria and
mycoplasma; TLR4 and TLR5 homodimers recognize lipopolysac-
charides (LPS) from Gram-negative bacteria and flagellin in
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flagellate bacteria, respectively; and TLR3, 7, 8, and 9 homod-
imers respond to various forms of bacterial and viral nucleic
acids (Gay & Gangloff, 2007). TLR stimulation initiates intracellu-
lar signaling cascades that lead to the production of anti-microbial
genes such as the proinflammatory cytokines interleukin (IL)-1
and IL-6, tumor necrosis factor-a (TNF-a), and type I and II inter-
ferons (IFN-a/-b/-c), which help orchestrate the innate anti-
pathogen immune response (Kawai & Akira, 2010). These pro-
inflammatory signaling networks are tightly regulated to ensure
that cells mount a robust and timely response to pathogens while
concomitantly guarding against excessive and sustained inflamma-
tion, which may promote the development of chronic inflamma-
tory diseases.
Recent microarray and RNA sequencing data have shown that
immune responses alter the expression of hundreds of lncRNAs
(Carpenter et al, 2013; Rapicavoli et al, 2013; Li et al, 2014;
Atianand et al, 2016; Wang et al, 2017), many of which are
trans-acting regulators of protein-coding genes (Chen et al,
2017). For example, in TLR1/2-stimulated THP1-derived human
macrophages, the lncRNA THRIL regulates TNF-a expression in
trans by forming a complex with the ribonucleoprotein (RNP)
hnRNPL that acts at the TNF-a promoter (Li et al, 2014). In
another study, lincRNA-COX2 was found to trans-regulate
inflammatory gene expression in LPS-stimulated bone marrow-
derived dendritic cells by interacting with hnRNP-A/B and
hnRNP-A2/B1 (Carpenter et al, 2013). NEAT1 is another trans-
acting lncRNA that stimulates TLR3-stimulated IL-8 expression in
HeLa cells by binding to the splicing factor SFPQ, thereby induc-
ing SFPQ translocation away from the IL-8 promoter (Imamura
et al, 2014). While these studies confirm the importance of trans
activity of lncRNAs in regulating innate immune responses, there
remains a large gap in our understanding of the extent to which
cis-regulatory lncRNAs contribute to physiological and pathogenic
inflammatory responses.
Here, we sought to identify global changes in coding and
noncoding gene expression during the innate immune response
of macrophages to TLR ligands. We identified 229 differentially
expressed lncRNAs located within 5 kb of protein-coding genes
with immune-related functions, suggesting that they may be cis-
regulatory lncRNAs with important roles in innate immunity.
Consistent with this, three of the identified cis-acting lncRNA-
coding gene pairs, lnc-MARCKS, lnc-BCAT1, and lnc-BAIAP2,
were shown to regulate inflammatory gene expression in macro-
phages stimulated with a panel of TLR ligands or infected a
leading human bacterial pathogen, group B Streptococcus (GBS).
We investigated the function and regulatory mechanism of lnc-
MARCKS, which we named Regulator of Cytokines and
Inflammation (ROCKI), in more detail. We found that ROCKI
regulated expression of its cognate protein-coding gene myristoy-
lated alanine-rich protein kinase C (MARCKS) by forming an
RNP complex at the MARCKS promoter with apurinic/apyrimi-
dinic endodeoxyribonuclease 1 (APEX1). Notably, the APEX1–
ROCKI complex induced recruitment of histone deacetylase
HDAC1 to the promoter, which led to a reduction in the active
enhancer mark H3K27ac and suppression of MARCKS transcrip-
tion. In turn, ROCKI-mediated negative regulation of MARCKS
promoted inflammatory cytokine and chemokine production.
Finally, we identified genetic variants of ROCKI in human
monocytes that are significantly associated with a reduced risk
of inflammation-related (e.g., inflammatory bowel disease) and
infection-related (e.g., Mycobacterium tuberculosis) disease pheno-
types in humans.
Collectively, our findings advance our understanding of the
mechanisms by which cis-acting lncRNAs regulate gene expression
in response to bacterial and viral infections, and also suggest that
ROCKI-regulated expression of MARCKS may contribute to
inflammatory diseases.
Results
TLR signaling induces genome-wide changes in LncRNA- and
protein-coding genes
To understand the global changes in protein-coding and noncoding
gene expression induced by TLR activation, we analyzed the human
THP1 monocyte cell line, which can be differentiated into macro-
phage-like cells by treatment with phorbol-12-myristate-13-acetate
(PMA). These cells are commonly used to study TLR-mediated
responses against bacterial and viral pathogens. To identify the opti-
mal stimulation time, the cells were incubated for 2, 4, or 8 h with
vehicle or one of three TLR ligands; Pam3CSK4 (Pam3), a bacterial
triacyl lipoprotein mimetic and TLR1/2 ligand; Pam2CGDPKHPKSF
(FSL-1), a synthetic diacyl lipoprotein from Mycoplasma salivarium
and TLR2/6 ligand; or LPS from Escherichia coli K12, a TLR4 ligand.
RT–qPCR analysis revealed that expression of the proinflammatory
genes IL8 and IL12B peaked at 8 h after stimulation (Fig EV1A–C).
RNA-seq analysis also identified numerous differentially expressed
protein-coding and lncRNA-coding genes in cells stimulated for 8 h
by Pam3, FSL-1, or LPS compared with unstimulated cells (Fig 1A
and B). The Circos plots in Fig 1 highlight changes in expression of
two representative protein-coding genes (NFjB, IFIT1) (Lemaitre,
2004) and two lncRNA-coding genes (NEAT1, Lnc-DC) (Imamura
et al, 2014; Wang et al, 2014), all of which are involved in host
immune responses and are dynamically regulated in response to
Pam3, LPS, and FSL-1 stimulation.
Identification of Cis-acting LncRNAs and protein-coding genes
associated with TLR signaling
Although lncRNAs can regulate protein-coding gene expression by
acting in cis or in trans, we focused here on identifying cis-regula-
tory lncRNAs in TLR-stimulated THP1-derived macrophages. We
performed bioinformatics analysis of the differentially expressed
paired lncRNA-coding and protein-coding genes in Pam3-, LPS-, and
FSL-stimulated cells, and we selected all gene pairs located within
5 kb of each other (Fig 1C, Table EV1). Previous work has shown
that most cis-acting lncRNA genes are located within 5 kb of their
corresponding regulated protein-coding genes (Mondal et al, 2010;
Orom et al, 2010; Cabili et al, 2011; Sigova et al, 2013; Luo et al,
2016).
Our analysis identified 229 candidate lncRNA-coding and
protein-coding gene pairs, of which 116, 120, and 140 pairs were
differentially expressed in cells stimulated with FSL-1, LPS, and
Pam3, respectively, and 41 gene pairs were commonly regulated by
all three TLRs (Fig 1E). Among the 229 lncRNAs, 203, 25, and 4
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Figure 1. Identification of cis-acting LncRNAs associated with innate immunity.
A, B THP1-derived macrophages were treated with the TLR ligands Pam3, lipopolysaccharide (LPS), or FSL-1 and analyzed by RNA-seq 8 h later. Circos plots show
genome-wide differential expression of protein-coding genes (A) and non-protein-coding genes (B) between untreated and treated macrophages. The outermost to
innermost circles show downregulated (blue) or upregulated (red) genes in cells stimulated with FSL-1, LPS, and Pam3, respectively. Chromosomes are indicated by
the numbers 1–22 and X and Y.
C Schematic showing cis-acting lncRNAs and protein-coding genes within 5 kb.
D Classification of lncRNA- and protein-coding gene pairs modulated by TLR ligands according to their biotypes. Pie charts show the proportion of each pair of genes
classified as XH (antisense head-to-head), XT (antisense tail-to-tail), XI (antisense inside), XO (antisense outside), SD (sense downstream), and SU (sense upstream).
E LncRNA- and protein-coding gene pairs commonly upregulated or downregulated in THP-1-derived macrophages stimulated with FSL-1, LPS, or Pam3 for 8 h.
F RT–qPCR validation of differentially expressed lncRNAs and mRNAs in THP1-derived macrophages stimulated for 8 h with flagellin (FLA), FSL-1, imiquimod, LPS,
Pam3, or poly(I:C). Heat map shows the fold change in expression of 13 mRNAs (left) and lncRNAs (right).
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were found to be potential cis-regulators of 1, 2, and 3 protein-
coding genes, respectively (Table EV1). We further classified these
lncRNAs into six locus biotypes based on their orientation to the
protein-coding gene (Fig 1D): XH, antisense head-to-head; XT, anti-
sense tail-to-tail; XI, antisense inside; XO, antisense outside; SD,
sense downstream; and SU, sense upstream, as described previously
(Luo et al, 2016). The largest lncRNA biotype modulated by the
TLRs was divergent XH, comprising 35.15, 34.85, and 34.33% of
total lncRNAs differentially expressed in Pam3-, FSL-1-, and LPS-
stimulated THP1-derived macrophages, respectively (Fig 1D). These
results indicate that a large number of cis-acting lncRNA genes are
non-randomly distributed in the genome and potentially play a role
in regulating innate immune responses.
Cis-acting LncRNAs regulate expression of nearby
protein-coding genes
To narrow down our functional analyses, we analyzed the 41 gene
pairs commonly regulated by Pam3, LPS, and FSL-1 (Figs 1E and
EV1D–F) and selected the 13 most differentially expressed pairs
(log2-fold change in expression of > 2 or < 2), 10 of which were
upregulated and 3 were downregulated. We then validated their dif-
ferential expression by RT–qPCR of FSL-1, LPS- and Pam3-treated
THP1-derived macrophages (Fig 1F). To determine whether these
gene pairs were modulated by other TLRs, we also analyzed their
expression in cells stimulated with Salmonella Typhimurium
flagellin (FLA), poly(I:C), and imiquimod, which are TLR5, 3, and 7
ligands, respectively. Notably, the 13 gene pairs showed similar
patterns of expression in response to all six TLR ligands (Fig 1F),
supporting their potential importance in innate immunity.
Next, we examined the effects of the cis-acting regulatory
lncRNAs on their cognate protein-coding genes. lncRNA expres-
sion was silenced in THP1-derived macrophages by infection with
lentiviruses encoding control or targeted shRNAs for 4 days, and
relative gene expression was analyzed by RT–qPCR. We used a
pool of 2–5 shRNAs per lncRNA, each targeting different gene
regions, to eliminate potential off-target effects and to enhance
the knockdown (KD) efficiency. Of the 13 gene pairs examined,
eight pairs were confirmed to have a cis-regulatory relationship
(Fig 2A). Macrophages depleted of lnc-MARCKS and lnc-BCAT1
showed significantly enhanced expression of the protein-coding
genes MARCKS, and BCAT1, respectively, compared with control
shRNA-expressing cells, which confirmed that these lncRNAs are
negative regulators of the linked genes. lnc-WT1 showed a moder-
ate effect to negatively regulate WT1 gene (Fig 2A). In contrast,
KD of lnc-ANKRD33B, lnc-BAIAP2, lnc-TNFAIP3, lnc-TMC6, and
lnc-NRG1 significantly reduced expression of the cognate protein-
coding genes, suggesting that these are positive cis-regulatory
lncRNAs (Fig 2A). lnc-BCAT1, lnc-WT1, lnc-BAIAP2, and lnc-
TNFAIP3 were identified as XH lncRNAs (antisense head-to-head),
lnc-MARCKS as an XT lncRNA (antisense tail-to-tail), and lnc-
TMC6, lnc-ANKRD33B, and lnc-NRG1 as SD lncRNAs (sense
downstream) (Figs 1D and 2A).
Characterization of the cis-regulatory LncRNAs
Because most of the lncRNAs identified here were annotated based
on bioinformatics predictions, we performed rapid amplification of
cDNA ends (RACE) to confirm their location and to determine the
50 and 30 end sequences of the uncharacterized lncRNAs. From
these experiments, we found that lnc-ANKRD33B and lnc-NRG1,
which were predicted to be in the sense strand overlapping the
corresponding protein-coding genes, were in fact isoforms of the
protein-coding genes. lnc-MARCKS, lnc-BCAT1, lnc-BAIAP2, and
lnc-TNFAIP3 were confirmed to be bona fide transcripts, and the
predicted sequences were authenticated (Fig EV2A). We identified
two isoforms of lnc-BAIAP2 and lnc-TNFAIP3 and only one form of
lnc-MARCKS and lnc-BCAT1 (Fig EV2A). Thus, among the 13 gene
pairs functionally tested here, 6 (46%) included cis-acting
lncRNAs. This demonstrates the power of our prediction methods
to identify cis-acting lncRNAs. Interestingly, five of the six lncRNAs
were antisense to their protein-coding genes, strongly suggesting
that divergent (XH and XT) biotypes are enriched among cis-acting
lncRNAs.
Cis-acting LncRNAs regulate cytokine production in response to
group B streptococcus (GBS) infection
To confirm the relevance of the identified gene pairs in the response
to live bacterial infection, we used the Gram-positive pathogen GBS
as a model system to activate TLR2 signaling (Lehnardt et al, 2006;
Henneke et al, 2008). THP1-derived macrophages were infected
with pooled lentiviruses encoding 2–5 shRNAs against lnc-BAIAP2,
lnc-MARCKS, lnc-WT1, lnc-BCAT1, lnc-TMC6, or their corresponding
protein-coding genes BAIAP2, MARCKS, WT1, BCAT1, or TMC6. All
gene pairs were shown by RT–qPCR to be silenced with good
efficiencies (Fig EV2B). Three days later, the cells were infected
with GBS (multiplicity of infection = 10 bacteria/macrophage) for
1 h, after which gentamicin was added to kill extracellular bacteria,
and the cells were collected for RT–qPCR analysis 10 h later.
Expression of IL-6 and IL-1a, two potent proinflammatory genes
induced by GBS infection, was significantly enhanced by KD of
BAIAP2, lnc-BAIAP2, MARCKS, WT1, and BCAT1 and significantly
suppressed by KD of lnc-MARCKS and lnc-BCAT1 (Fig 2B–D).
Although KD of lnc-WT or lnc-TMC6 also had modest effects on IL-6
expression, the differences were not statistically significant (Fig 2C).
These results substantiate the predicted mode of action of
lnc-BAIAP2 as a positive cis-regulator and of lnc-MARCKS and
lnc-BCAT1 as negative cis-regulators of their corresponding protein-
coding genes. The data also confirm the involvement of these three
gene pairs in regulating proinflammatory cytokine expression during
GBS infection.
The long noncoding RNA, lnc-MARCKS, is a positive regulator of
inflammatory responses
We observed a global regulation of lnc-MARCKS on other cytokine
and chemokine expressions, such as CXCL1, IL-24, and CCL3
(Figs 1F and 2B–D, see below Fig 6), suggesting its role as a master
regulator of innate immunity. Therefore, lnc-MARCKS was chosen
for further investigation.
To determine the lnc-MARCKS function by an alternative
approach, THP1 cells were transduced with CRISPR inhibitor system
(CRISPRi) targeting lnc-MARCKS (Gilbert et al, 2013). Two sgRNAs
were designed to target lnc-MARCKS (Fig 3A) and > 80% inhibition
of lnc-MARCKS was achieved (Fig 3B). Consistent with the results of
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our functional analysis by RNAi (Fig 2B–D), CRISPRi of lnc-
MARCKS increased MARCKS expression (Fig 3C) and caused repres-
sion of IL-6 induction in sgRNA-expressed cells (Fig 3D), indicating
that lnc-MARCKS was a negative regulator of MARCKS and positive
regulator of inflammation responses. Additionally, overexpression
of an approximately 2.7-kb transcript of lnc-MARCKS (identified by
RACE; Fig 3E) in THP1-derived macrophages significantly downreg-
ulated basal MARCKS mRNA (Fig 3F) levels and increased IL-6
A
B C D
Figure 2. Cis-acting LncRNAs regulate nearby genes and cytokine production in response to group B Streptococcus (GBS) infection.
A Activation and suppression of nearby genes by eight cis-acting lncRNAs. RT–qPCR analysis of THP1-derived macrophages transduced with lentiviruses expressing
non-targeting control (NC) shRNA or shRNAs targeted to the indicated lncRNAs and protein-coding genes. Mean  SD of n = 3. *P < 0.05, **P < 0.01, ***P < 0.005,
****P < 0.0001 by Student’s t-test.
B–D Silencing of cis-regulated gene pairs affects GBS-induced expression of IL-6 (B and C) and IL-1a (D). RT–qPCR analysis (B and D) or IL-6 ELISA quantification (C) of
THP1-derived macrophages transduced with the indicated NC or targeting shRNAs for 72 h, infected with GBS for 1 h, and then treated with gentamicin for
30 min to terminate infection. RT–qPCR and ELISA were performed at 10 h post-infection. Mean  SD of n = 3. *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.0001
by Student’s t-test.
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mRNA levels upon Pam3 stimulation (Fig 3G). Further characteriza-
tion showed that the lnc-MARCKS RNA was present in THP1 macro-
phages at  6 copies per cell and mainly distributed in nucleus
(Fig EV3A). A small proportion of lncRNAs undergo translation and
could encode stable and functional peptides (Housman & Ulitsky,
2016; Hezroni et al, 2017). To determine whether lnc-MARCKS lacks
protein-coding potential or not, we predicted the possible proteins
in lnc-MARCKS using SnapGene software and found one ORF (93aa)
near the 30-end. However, the coding product cannot be aligned to
any known proteins (Fig EV3B). These analyses suggested that lnc-
MARCKS did not code for small peptides. In addition, ribosome
footprinting data from GWIPS shows very weak ribosomal binding
on lnc-MARCKS, which suggest that lnc-MARCKS is a noncoding
RNA (Fig EV3C) (Ingolia et al, 2009). To further confirm the
noncoding potential of lnc-MARCKS, we fused lnc-MARCKS
sequences to the reading frame of a Flag tag and transfected the
vectors into 293T cells. Notably, anti-Flag Western blot analysis
failed to detect any protein expression from the constructs, con-
firming that lnc-MARCKS is a bona fide noncoding RNA (Fig EV3D).
To further strengthen the biological significance of lnc-MARCKS,
we generated primary human macrophages and silenced lncRNA-
MARCKS expression by using an antisense oligo targeting the RNA
A B C D
E
G H JIF
Figure 3. lnc-MARCKS negatively regulates MARCKS expression and promotes inflammatory responses.
A–D Repression of lnc-MARCKS using CRISPRi increased MARCKS expression and decreased IL-6 induction. (A) Illustration of CRISPRi system and the relative locations of
the two sgRNAs. (B-D) lnc-MARCKS (B), MARCKS (C), and IL-6 (D) expressions were quantified in cells stably expressing dCas9/KRAB/BFP and the NC or sgRNAs.
Mean  SD of n = 3. **P < 0.01, ***P < 0.005, ****P < 0.0001 by Student’s t-test.
E The lnc-MARCKS gene locus. The full-length sequence of lnc-MARCKS was obtained by rapid amplification of cDNA ends (RACE). lnc-MARCKS is located on human
chromosome 6 and encompasses 2 exons.
F, G Overexpression of lnc-MARCKS decreases MARCKS expression and enhances IL-6 expression. RT–qPCR analysis of THP1 cells transduced with lentiviruses expressing
empty vector (E.V.) or lnc-MARCKS, treated with PMA overnight, and left unstimulated or stimulated with Pam3 for 8 h. lnc-MARCKS and MARCKS expression (F), IL-6
expression (G). Mean  SD of n = 3. ***P < 0.005 by Student’s t-test.
H–J lnc-MARCKS regulates MARCKS and IL-6 in primary macrophages. Primary macrophages were transfected with NC or lnc-MARCKS antisense oligo to knock down lnc-
MARCKS expression. 48 h later, cells were stimulated with Pam3 for 8 h and harvested to detect lnc-MARCKS (H), MARCKS (I), and IL-6 expressions (J). Mean  SD of
n = 3. *P < 0.05, **P < 0.01 by Student’s t-test.
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AB C
D E
Figure 4. ROCKI (lnc-MARCKS) binds to the MARCKS Promoter and Interacts with APEX1.
A ROCKI is recruited to the MARCKS promoter in Pam3-stimulated THP1-derived macrophages. ChIRP analysis of THP1-derived macrophages treated with Pam3 for 8 h.
ChIRP assays were performed using a non-specific lacZ probe or probes specific for lnc-MARCKS. Specificity of ROCKI probes (left), and enrichment at the MARCKS
promoter (right). Probes are listed in Table EV2. Mean  SD of n = 3. **P < 0.01, ***P < 0.005 by Student’s t-test.
B Mass spectrometry identifies APEX1 as a candidate ROCKI-binding protein in THP1-derived macrophages. APEX1 MS/MS count represents the ratio between the
number of APEX1 peptides and all peptides detected. Mean of n = 2 samples. ROCKI and ROCKI-AS represent ROCKI and antisense strand of ROCKI transcripts,
respectively.
C ROCKI inhibition of MARCKS expression is dependent on APEX1. RT–qPCR analysis of MARCKS, ROCKI, and APEX1 expression in THP1-derived macrophages
overexpressing ROCKI and/or depleted of APEX1. Mean  SD of n = 3. ***P < 0.001 by Student’s t-test.
D APEX1 specially binds to ROCKI. Western blot analysis of APEX1 in lacZ, or ROCKI pull-down fractions. Vimentin, which non-specifically binds to all RNA probes, is
shown as a loading control.
E ROCKI associates with APEX1. Left: RT–qPCR analysis of ROCKI present in anti-APEX1 antibody or control IgG immunoprecipitates from nuclear lysates of Pam3-treated
THP1-derived macrophages. Right: APEX1 Western blot of the same immunoprecipitates. Mean  SD of n = 4. ****P < 0.0001 by Student’s t-test.
Source data are available online for this figure.
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region at 1,887–1,907 nucleotides. Consistent with the shRNA and
CRISPRi results (Figs 2B–D and 3A–D), lnc-MARCKS silencing by
ASO increased MARCKS expression and repressed IL-6 induction as
compared with cells transfected with a control ASO (Fig 3H–J).
Taken together, these results identify lnc-MARCKS as a positive
regulator of the inflammatory macrophage response. Therefore, we
re-named this lncRNA ROCKI (Regulator of Cytokines and
Inflammation).
ROCKI functions by binding to the MARCKS distal promoter where
it interacts with APEX1
To investigate the mechanism by which ROCKI cis-regulates
MARCKS expression, we first performed chromatin isolation by RNA
purification (ChIRP) assays to assess ROCKI binding to the MARCKS
promoter. For this, we used an antisense oligonucleotide tiling
method that encompassed the entire ROCKI sequence (Li et al, 2014;
Lin et al, 2014). Chromatin fractions from control or Pam3-treated
THP1-derived macrophages were incubated with biotinylated ROCKI
or control (lacZ) RNA probes and analyzed by RT–qPCR for the
presence of MARCKS promoter regulatory sequences. We designed
six PCR primers spanning from 1,370 to +87 relative to the +1 tran-
scription start site. By analogy to the conserved murine MARCKS
sequence, this region was expected to include a distal promoter and
a core promoter (Harlan et al, 1991; Wang et al, 2002). We
observed that biotinylated ROCKI was significantly enriched
compared to the control probe (Fig 4A, left). Importantly, RT–qPCR
analysis of the sequences pulled down with ROCKI showed specific
enrichment of the 1,370/1,140 and 1,158/1,060 MARCKS
promoter sequences, indicating that ROCKI bound to the distal,
rather than the proximal, promoter (Fig 4A).
We next asked whether ROCKI acted alone at the MARCKS
promoter or might functions as part of an RNP. To identify ROCKI-
binding proteins, we in vitro-transcribed and biotinylated ROCKI,
antisense ROCKI, or a partial lacZ mRNA sequence (without protein-
coding capacity) and incubated them with nuclear proteins isolated
from Pam3-treated THP1-derived macrophages. The associated
proteins were then pulled down and analyzed by mass spectrome-
try. We identified the 10 most enriched ROCKI-binding proteins as
APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1), NUDT21
(NUDIX Hydrolase 21), RCC2 (regulator of chromosome condensa-
tion 2), HMGB2 (high mobility group box 2), HMGB3 (high mobility
group box 3), HSD17B4 (hydroxysteroid 17-beta dehydrogenase 4),
KHSRP (KH-type splicing regulatory protein), NCL (neuronal ceroid
lipofuscinoses), CIRBP (cold-Inducible RNA binding protein), and
ELAVL1 (ELAV like RNA binding protein 1) based on the number of
peptides specifically associated with ROCKI (Figs 4B and EV4A,
Table EV3).
To determine whether these candidate ROCKI-binding proteins
function in regulating MARCKS expression, we transfected THP1-
derived macrophages with shRNAs against each gene and
performed RT–qPCR analysis to confirm they were efficiently
knocked down (Fig EV4C). Among the 10 genes examined, silencing
of APEX1 alone significantly affected MARCKS expression, inducing
~2-fold increase in the level of MARCKS transcripts compared with
the control shRNA-transfected cells (Fig EV4B). Notably, ROCKI-
induced suppression of MARCKS inhibition was rescued by co-trans-
fection of THP1-derived macrophages with shAPEX1, indicating that
ROCKI-mediated inhibition of MARCKS expression was dependent
on APEX1 (Fig 4C).
We also performed pull-down assays with in vitro-transcribed
biotinylated ROCKI or lacZ RNA followed by Western blotting with
anti-APEX1 antibody, which confirmed that APEX1 specifically
interacts with ROCKI (Fig 4D). To further confirm the APEX1-RNA
interactions by an alternative experiment, we performed immuno-
precipitation of endogenous APEX1 from nuclear extracts of THP1-
derived macrophages followed by RT–qPCR and the results revealed
 40-fold enrichment of ROCKI in the anti-APEX1 immunoprecipi-
tates compared to the IgG control (Fig 4E). Taken together, these
results demonstrate that ROCKI and APEX1 form an RNP complex
that regulates MARCKS expression.
ROCKI–APEX1 ribonucleoprotein complex facilitates HDAC1-
mediated remodeling of the MARCKS promoter
Next, we sought to understand how the ROCKI–APEX1 complex
regulates MARCKS expression. We hypothesized that ROCKI may
recruit APEX1 to the MARCKS promoter. To test this, we performed
chromatin immunoprecipitation (ChIP) assays by immunoprecipitat-
ing endogenous APEX1 protein from nuclear lysates of THP1-
derived macrophages, eluting the associated DNA, and performing
RT–qPCR analysis to probe for the presence of MARCKS promoter
sequences. Indeed, APEX1 immunoprecipitates contained higher
levels of the two MARCKS promoter sequences tested compared
with control IgG immunoprecipitates (Fig 5A). Since APEX1 enrich-
ment was impaired in ROCKI KD cells (Fig 5B), these data support
our hypothesis that ROCKI recruits APEX1 to form an RNP at the
MARCKS promoter. Importantly, ROCKI KD had no significant effect
on APEX1 binding to the b-actin promoter (ACTB2), highlighting the
specific function of ROCKI–APEX1 in regulating MARCKS expression
(Fig 5B).
APEX1 is known to repress expression of human parathyroid
hormone and renin by binding to the negative regulatory calcium-
response element in the promoters and recruiting HDAC1, which
removes the activating chromatin mark H3K27ac3 and reduces
gene transcription (Bhakat et al, 2003; Fuchs et al, 2003). To
determine whether APEX1 might act similarly to suppress MARCKS
transcription, we first performed Western blotting to probe for the
presence of HDAC1 in anti-APEX1 immunoprecipitates from
nuclear lysates of control or shROCKI-expressing THP1-derived
macrophages. These results show that HDAC1 associates with
APEX1 in the nucleus and this interaction was not dependent on
ROCKI expression (Fig 5C, left). RT–qPCR was performed to show
the successful pull down of ROCKI in APEX1 immunoprecipitates
and successful silencing in ROCKI-knockdown cells (Fig 5C right).
We next analyzed the level of HDAC1 and H3K27ac at the
MARCKS promoter in these cells by performing ChIP assays with
an anti-HDAC1 or anti-H3K27ac antibody (Fig 5D and E). As
expected, HDAC1 and H3K27ac immunoprecipitates were enriched
in the two MARCKS promoter sequences and the ACTB2 sequence,
but only MARCKS sequence enrichment was significantly
decreased in HDAC1-CHIP (Fig 5D), while increased in H3K27ac-
CHIP (Fig 5E) by ROCKI KD. Taken together, these results show
that ROCKI interacts with APEX1 to recruit HDAC1 to the MARCKS
promoter, leading to a reduction in H3K27ac and repression of
MARCKS transcription.
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Figure 5. ROCKI reduces H3K27ac modification of the MARCKS promoter via APEX1 binding and recruitment of HDAC1.
A ChIP analysis of THP1-derived macrophages demonstrates APEX1 recruitment to the MARCKS promoter. RT–qPCR analysis of fragments of the MARCKS promoter
region (a and b) or a non-specific region (nc) co-immunoprecipitated with anti-APEX1 antibody. Mean  SD of n = 4. ****P < 0.0001 by Student’s t-test.
B ChIP analysis of APEX1 recruitment to the MARCKS promoter was performed as described for (A) except the cells expressed non-targeting control (NC) or ROCKI shRNA
and treated with Pam3 for 8 h. The y-axis shows the percentage of enrichment in normalized to input. An unrelated region of the ACTB2 promoter was amplified as a
control. Mean  SD of n = 4. **P < 0.01. ****P < 0.0001, ns, non-significant by Student’s t-test.
C Left: Western blot analysis of APEX1 and HDAC1 in control rabbit IgG or anti-APEX1 antibody immunoprecipitates from NC (control) or ROCKI-knockdown THP1-
derived macrophages. Right: RT–qPCR analysis of ROCKI in the same immunoprecipitates.
D Knockdown of ROCKI decreased HDAC1 enrichment on the MARCKS promoter. ChIP-qPCR analysis of HDAC1 was performed as described for (A) using an anti-HDAC1
antibody. Mean  SD of n = 3. *P < 0.05, ****P < 0.0001, ns, non-significant by Student’s t-test.
E Knockdown of ROCKI enhances H3K27ac deposition on the MARCKS promoter. ChIP-qPCR analysis of H3K27ac was performed as described for (A) using an anti-
H3K27ac antibody. Mean  SD of n = 3. ****P < 0.0001, ns, non-significant by Student’s t-test.
Source data are available online for this figure.
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ROCKI regulates proinflammatory gene expression
To investigate how the ROCKI–APEX1–HDAC1–MARCKS axis regu-
lates the innate inflammatory response in THP1-derived macro-
phages, we performed genome-wide RNA sequencing and analyzed
differential gene expression changes in MARCKS KD- or ROCKI-over-
expressing cells after stimulation with Pam3 for 8 h. Genes differen-
tially regulated by both ROCKI overexpression (800 upregulated and
1,435 downregulated) and MARCKS KD (219 upregulated and 294
downregulated) were selected based on a significant (P < 0.05) log2-
fold change of > 1 or < 0.5. We identified 128 genes that were
considered to be commonly upregulated by both ROCKI and
MARCKS, while 154 genes were identified to be commonly downreg-
ulated (Fig 6A and Table EV4). Notably, Gene Ontology analysis
showed that the upregulated genes were significantly enriched in
terms related to inflammatory responses (Fig EV5A). Among the
most significantly upregulated genes were multiple cytokines,
chemokines, and migration factors (Fig 6B); of these genes, we con-
firmed the lncRNA effects on 10 by RT–qPCR (Fig 6C).
In addition, we observed that these commonly regulated genes
are highly overlapped with immune pathways, including the IL-17
signaling pathway, IL-1 signaling in melanoma, and histamine H1
receptor signaling in immune responses (Fig EV5C). In the hista-
mine H1 receptor signaling, Ca2+ initiates the inflammation
response by binding to PKCa (Fig EV5C). Since MARCKS protein is
a well-characterized modulator of Ca2+ signaling (Hartwig et al,
1992; Gadi et al, 2011; Rodriguez Pena et al, 2013) and APEX1 can
be acetylated by calcium activation to modulate its transcriptional
Up-Regulated genes
shMARCKS
ROCKI
shMARCKS
ROCKI
Pam3CSK4
A
D
C
91
128
672
B
Down-Regulated genes
140 154 1281
shMARCKS
ROCKI
Figure 6. ROCKI and MARCKS are Ca2+ regulators in TLR1/2 signaling.
A Identification of genes regulated by both ROCKI and MARCKS by RNA-seq of ROCKI-overexpressing or MARCKS-knockdown THP1-derived macrophages stimulated with
Pam3 for 8 h.
B Heatmap of representative genes commonly upregulated in ROCKI-overexpressing and MARCKS-knockdown THP1-derived macrophages.
C RT–qPCR validation of inflammatory gene expression in ROCKI-overexpressing and MARCKS-knockdown THP1-derived macrophages stimulated with Pam3 for 8 h.
E.V., empty vector; NC, control shRNA. Mean  SD of n = 4. *P < 0.05, **P < 0.01, ***P < 0.001 by Student’s t-test.
D MARCKS is a negative regulator of Ca2+ signaling. Fluo-4 fluorescence of MARCKS, ROCKI, or NC (control) shRNA-expressing THP1-derived macrophages before and
after treatment with PMA and Pam3. Triton X-100 was added to obtain the maximal [Ca2+] signal. Fluorescence levels are expressed as the change in signal
normalized to the maximal fluorescence (DF/Fmax).
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regulatory function (Bhakat et al, 2003, 2009), we asked whether it
might play a similar role in Pam3-stimulated THP1-derived macro-
phages. To test this, we loaded cells expressing control, MARCKS, or
ROCKI shRNA with the Ca2+-sensitive fluorescent dye Fluo-4 and
examined the change in fluorescence signal after Pam3 stimulation.
As shown in Fig 6D, cytoplasmic Ca2+ levels were increased by
MARCKS KD and decreased by ROCKI KD compared with control
cells, suggesting that the ROCKI–MARCKS axis may regulate
cytokine production in TLR-stimulated macrophages via Ca2+
signaling pathways.
Genetic links between ROCKI and inflammation- and infection-
related phenotypes
Finally, we used genetic variation to explore whether ROCKI func-
tion is linked to human disease phenotypes. We first sought to
A B
D
C
MARCKS
ROCKI
HDAC2
HS3ST5
FLJ34503
HDAC2-AS2
Figure 7. Genetic link between ROCKI and human disease and a model for ROCKI function.
A QTL signals for ROCKI (LINC01268) gene expression in whole blood (top, black), H3K27ac promoter signal in monocytes (middle, green), and H3K4me1 signal in
monocytes (bottom, orange) in a 400-kb window around the MARCKS/ROCKI locus. The signals were strongly co-localized (Pshared = 0.97, Pshared = 0.98), suggesting
they represent the same signal.
B Signed test statistics from UK Biobank association data for 1,463 disease- or medication-related traits for rs9387181. Black crosses denote the mean  SEM for each
group. Dotted horizontal line indicates the null.
C RT–qPCR analysis of ROCKI expression in dendritic cell samples from uninfected and M. tuberculosis-infected donors. Mean  SD of n = 6. ***P < 0.001 by Student’s
t-test.
D A cis-regulatory model for ROCKI function in the negative regulation of MARCKS in innate immune cells. Upon TLR activation, ROCKI binds to the MARCKS promoter
region and recruits APEX1, which facilitates HDAC1-mediated removal of the H3K27ac modification, thereby inhibiting MARCKS expression.
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identify cis variants that affect ROCKI expression using quantitative
trait loci (QTL) data. We obtained whole blood expression QTL
(eQTL) data from the GTEx project v7 release (GTEx Consortium
et al, 2017). There was a significant ROCKI eQTL for variants
upstream of the promoter (Fig 7A). These variants did not show
evidence for significant eQTL association with MARCKS, confirming
a primary effect on ROCKI (Fig EV6A). To further determine the
effects of these variants in monocytes, we analyzed CD14+ mono-
cyte QTL datasets for H3K4me1 and H3K27ac signal from the BLUE-
PRINT epigenome project (Chen et al, 2016). For the same ROCKI
eQTL variants, there were also significant QTLs for H3K27ac signal
directly at the ROCKI promoter and H3K4me1 signal in a broader 35-
kb region spanning both MARCKS and ROCKI (Fig EV6). There was
both strong co-localization and directional consistency in the ROCKI
expression, H3K27ac, and H3K4me1 QTLs (Pshared > .95), suggesting
they all represent the same association signal (Fig 7A). To determine
the variant responsible for the ROCKI QTL, we performed genetic
fine-mapping and calculated the posterior probability of association
(PPA) that each variant was causal for the QTL signal (see Experi-
mental Procedures). The most likely causal variant rs9387181
(PPA = 0.15) overlapped a regulatory region 6-kb upstream of
ROCKI annotated with DNase I hypersensitivity sites for monocytes
and ChIP-seq sites for immune transcription factors such as RELA
and IRF4 (Fig EV6B). These data thus identify cis-regulatory variants
that affect ROCKI activity in whole blood and monocytes.
We next determined the effects of the ROCKI cis-regulatory vari-
ants on human phenotypes. We obtained association data for 1464
disease-related phenotypes (UK Biobank) using the most probable
ROCKI eQTL variant rs9387181 to represent the association signal.
The ROCKI-reducing allele of rs9387181 was broadly correlated with
reduced risk of inflammatory and infection-related, cardiovascular,
and cognitive diseases and reduced use of the corresponding medi-
cations (Fig 7B). The most significant correlations for this variant
within each group included reductions in flucloxacillin treatment
(t = 3.3), prednisolone treatment (t = 2.8), atherosclerosis
(t = 2.99), tuberculosis infection (t = 2.5), and inflammatory
bowel disease (t = 2.5). These results thus provide genetic support
for a link between ROCKI function in whole blood cells and isolated
monocytes and the risk of inflammation- and infection-related
disease phenotypes. To probe further, we analyzed data from a
study of gene expression in human dendritic cells infected with
Mycobacterium tuberculosis (Pacis et al, 2015). Intriguingly, ROCKI
expression was significantly increased in the cells infected with
M. tuberculosis (Fig 7C), confirming the predicted association.
Collectively, the data presented here demonstrate a role for
the lncRNA ROCKI in innate immune function during human
pathogen infection. Our data support a model in which ROCKI
cis-regulates MARCKS expression via formation of an RNP with
APEX1 at the MARCKS promoter, which facilitates HDAC1-
mediated removal of H3K27ac, leading to reduced MARCKS
expression and suppression of Ca2+ signaling and inflammatory
cytokine production (Fig 7D).
Discussion
Activation of immune cells by pathogens leads to rapid and dynamic
changes in gene expression aimed at combating the infection.
Previous studies have demonstrated that the expression of hundreds
of lncRNAs is altered by stimulation of innate and adaptive immune
cells; however, their functions remain largely unknown (Carpenter
et al, 2013; Rapicavoli et al, 2013; Li et al, 2014; Atianand et al,
2016; Wang et al, 2017). Here, we analyzed the expression of
coding and noncoding genes in TLR-stimulated human macrophages
to identify cis-regulatory lncRNAs and protein-coding genes. We
identified 229 gene pairs with potential roles in immune regulation
and selected 13 candidate pairs that were commonly regulated by
six TLRs (TLR1/2, 2/6, 3, 4, 5, and 7) for functional validation.
Eight lncRNAs were confirmed to cis-regulate their corresponding
protein-coding genes. Of these, three (ROCKI, lnc-BCAT1, and lnc-
WT1) were negative regulators and five (lnc-ANKRD33B, lnc-NRG1,
lnc-TMC6, lnc-BAIAP2, and lnc-TNFAIP3) were positive regulators of
their cognate genes. Further analysis showed that lnc-ANKRD33B
and lnc-NRG1 overlapped with and were assumed to be isoforms of
their cognate coding genes. Interestingly, five of the remaining six
lncRNAs had antisense biotypes (XH: lnc-BCAT1, lnc-WT1, lnc-
BAIAP2, lnc-TNFAIP3, and XT: ROCKI). Antisense lncRNAs
comprise over 90% of genic lncRNAs (lncRNA < 5 kb to a coding
gene). Since > 60% of the 229 potential gene pairs identified here
include antisense lncRNAs (Mancek-Keber et al, 2012; Lee et al,
2015), we expect that further mining of our data will reveal vital
information about the landscape of functional lncRNAs in TLR
signaling.
Activation of TLRs regulates immune responses through a
highly controlled network of gene expression. Among the four
functional lncRNA-gene pairs, MARCKS, BCAT1, and WT1 were
induced by TLR ligands, acts in a negative feedback manner to
inhibit cytokine productions. These genes are “brakes” in control-
ling excessive immune response. In the meantime, ROCKI, lnc-
BCAT1, and lnc-WT1 were co-induced by stimuli, acting as a nega-
tive regulator of these brake genes to maintain the proper immune
responses. lnc-BAIAP2 positively regulated BAIAP2 expression, and
they were simultaneously decreased by TLR stimulus to promote
immune response (Fig 2A–D). All these results confirmed that TLR
pathways induce or suppress the expression of lncRNAs to turn on
a lncRNA-directed regulatory circuit, contributing to stricter and
tighter regulation of TLR network. The most abundant and promis-
ing antisense lncRNAs belong to XH group and their average
distance between the nascent transcription start sites is ~800 bp, a
distance that can be easily co-regulated on the genome. Local regu-
lation of gene expression by cis-lncRNAs may involve regulatory
components in gene promoters, the process of transcription or
splicing, or the sequence/structure of the RNAs. Although cis-regu-
lation by lncRNAs can be independent of the lncRNA transcripts
themselves and could involve the RNA transcription and splicing
mechanisms (Engreitz et al, 2016; Joung et al, 2017), but a
number of studies showed that cis-regulatory functions of lncRNAs
were dependent on the sequence/structure of the RNAs (reviewed
in Guil & Esteller, 2012 and Kopp & Mendell, 2018). For example,
a divergent lncRNA Evx1 cis-regulates adjacent coding genes based
on its sequence during lineage differentiation in pluripotent cells
(Luo et al, 2016). In our studies, ROCKI function was dependent
upon the lncRNA sequence and ectopic expression enhanced
inflammatory responses (Fig 3), representing an example of posi-
tive regulatory mechanism by lncRNA that is not a result of mere
proximity of transcription.
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We identified APEX1 as a ROCKI-binding protein; interestingly,
this protein has previously been reported to regulate TLR2-depen-
dent inflammatory responses in human keratinocytes (Lee et al,
2009). APEX1 can be acetylated by calcium activation to modulate
its transcriptional regulatory function (Bhakat et al, 2003, 2009).
Acetylated APEX1 binds more potently than the unacetylated
protein to the parathyroid hormone promoter to repress its tran-
scription (Bhakat et al, 2003). We observed a significant increase in
ROCKI binding to the MARCKS promoter in Pam3-stimulated THP1-
derived macrophages (Fig 4A). Further, APEX1 binding to MARCKS
promoter was increased in Pam3-stimulated THP1-derived macro-
phages (Fig 5A and B) because Pam3 activates calcium, which leads
to APEX1 acetylation and contributes to APEX1-ROCKI binding to
the promoter. APEX1 was confirmed to recruit HDAC1 to modify
histone acylation. We did not observe an enrichment of HDAC1 in
our in vitro pull-down assay. There are two plausible explanations
for this result: (i) This interaction is indirect binding, which is
dependent on bridging of APEX1 as we proposed in our model Fig 7.
(ii) This binding is temporal, thus hard to detect in the in vitro
binding assay.
Several studies have identified a role for MARCKS in the regula-
tion of inflammatory cytokine expression in myeloid cells. Treat-
ment of neutrophils with LPS induces MARCKS expression and leads
to its phosphorylation by protein kinase C (Aderem et al, 1988;
Thelen et al, 1990; Seykora et al, 1991). Moreover, incubation of
macrophages with peptides derived from the MARCKS effector
domain not only blocked MARCKS phosphorylation and its disasso-
ciation from the membrane but also suppressed LPS-induced activa-
tion of p38, JNK, and NF-jB, thereby inhibiting inflammatory
cytokine production (Lee et al, 2015). Another study proposed that
MARCKS sequesters LPS to negatively regulate TLR4 signaling
(Mancek-Keber et al, 2012). Here, we found that MARCKS expres-
sion was regulated not only by TLR4 but also by TLRs 1/2, 2/6, 2,
5, and 7, suggesting that it may be a master modulator of innate
immune responses. Consistent with this, MARCKS KD and ROCKI
overexpression increased the expression of dozens of inflammatory
factors, including chemokines and cytokines (Figs 2 and 6). Interest-
ingly, ROCKI overexpression regulated more genes involved in cyto-
kine and inflammation than MARCKS KD, for example, ILR2, IL1R1,
CXCL16, CXCL12, and IL18BP (Fig 6). A number of genes in MAPK
pathway were also induced by ROCKI overexpression, such as
MAPKAPK2, MAPK10, and MAPKAPK3 (Table EV4). It remains to
be determined whether ROCKI overexpression directly or indirectly
affected genes which were not altered by MARCKS KD.
In addition, we observed that these commonly regulated genes
highly overlapped with histamine H1 receptor signaling in immune
responses (Fig EV5C). In the histamine H1 receptor signaling, Ca2+
initiates the inflammation response by binding to PKCa (Fig EV5C).
Since MARCKS protein is a well-characterized modulator of Ca2+
signaling (Hartwig et al, 1992; Gadi et al, 2011; Rodriguez Pena
et al, 2013), we propose that MARCKS regulates inflammation by
controlling calcium release. As shown in Fig 6D, cytoplasmic Ca2+
levels were increased by MARCKS KD and decreased by ROCKI KD
compared with control cells. Thus, modulating Ca2+ signaling path-
ways could be a new mechanism for MARCKS to regulate inflamma-
tion responses.
Taken together, our study developed a new strategy to illustrate
lncRNAs with unknown function in TLR signaling. Importantly, we
observed a genetic link between ROCKI activity in blood and mono-
cytes and the risk of inflammation and infection-related disease
phenotypes. We believe that our findings will help us understand
the intact regulatory network of TLR signaling and also generate
better experimental designs when investigating lncRNA transcripts
in TLR signaling.
Materials and Methods
Cell culture
THP1 cells were cultured as described previously (Li et al, 2014).
In brief, THP1 cells were cultured in RPMI 1640 medium supple-
mented with 10% fetal bovine serum (FBS) and 50 lM b-mercap-
toethanol (Sigma). Cells were treated with 5 ng/ml phorbol-12-
myristate-13-acetate (PMA) overnight to induce differentiation into
macrophages, and the medium was replaced with PMA-free
medium the following day. 293FT cells were cultured in DMEM
supplemented with 10% FBS. Primary macrophages were gener-
ated by stimulating peripheral blood mononuclear cell (PBMC)
with M-CSF (10 ng/ml, R&D) for 7 days in RPMI 1640 medium
supplemented with 10% fetal bovine serum and 50 lM b-mercap-
toethanol.
Bacterial culture
GBS (serotype IA strain A909) was cultured overnight at 37°C with-
out shaking in Todd-Hewitt broth supplemented with 0.5% yeast
extract. Bacteria were grown to logarithmic phase (OD = 0.4 or ~10
colony-forming units per ml), the centrifuged, washed, and resus-
pended in DMEM, and serially diluted to the desired concentration.
For experiments, THP1-derived macrophages were inoculated with
GBS at a multiplicity of infection of 10 bacteria per cell.
TLR ligand treatment
Human TLR agonists were purchased from Invivogen (# tlrl-
kit1hw). Aliquots of 1 × 106 THP1-derived macrophages were
seeded in 6-well plates and incubated with Pam3 (100 ng/ml), LPS
(100 ng/ml), FSL-1 (100 ng/ml), flagellin (100 ng/ml), or
imiquimod (5 lg/ml). For poly(I:C) stimulation, cells were trans-
fected with 100 ng/ml poly(I:C) using Lipofectamine 3000 (Invitro-
gen) for 8 h. Cells were then washed with PBS and further
processed as required for each experiment.
Interleukin-6 (IL-6) ELISA
In Fig 2C, the human Interleukin-6 ELISA kit (R&D, DY20605) was
used for the quantitative determination of IL-6 expression in the
supernatant of THP1 cells stimulated by GBS for 10 h. ELISA was
performed following the protocol.
Library preparation and RNA-Seq
Approximately 0.5 lg total RNA per sample was depleted of riboso-
mal RNA using a RiboMinus kit (Life Technologies) and then
processed using NEBNext Ultra RNA Library Prep Kit for Illumina
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(New England BioLabs) with 15 cycles of PCR, according to the
manufacturer’s recommendations. The final libraries were size-
selected on 2% agarose gels to obtain products between 280 and
380 bases in length. The libraries were loaded onto an Illumina
HiSeq2000 for single-end 100 base-pair reads with 7 base index
reads.
Lentiviral-mediated gene knockdown and ROCKI overexpression
shRNAs against protein-coding genes were purchased from the
Functional Genomics Center (sequences listed in Table EV2).
shRNAs against lncRNAs were designed using the open-access tool
from the Broad Institute. Probes containing sense and antisense
strands of shRNAs were annealed and cloned into pLKO.1 lenti-
virus vector (Addgene) following the manufacturer’s instructions.
ROCKI was cloned into a pFLAG-CMV plasmid for ROCKI overex-
pression experiments. Primer sequences for cloning shRNAs and
ROCKI are listed in Table EV2. Lentiviruses were produced in
293FT cells using the protocol described previously (Khalil et al,
2009; Li et al, 2014). Briefly, aliquots of 1 × 106 cells/well were
seeded into 6-well plates 1 day before transfection. The next day,
lentiviral and packaging vectors (System Biosciences) were trans-
fected into 293FT cells using Lipofectamine 2000 (Invitrogen) and
virus-containing supernatants were collected 2 days after transfec-
tion. THP1 cells in 12-well plates (4 × 105/well) were transduced
using 500 ll viral supernatant in the presence of 4 lg/ml poly-
brene, and 20 ng/ml PMA was added to induce differentiation.
The transduction efficiency was enhanced by centrifuging the cell/
virus mixture at 750 g for 45 min.
Primary macrophages transfection with antisense oligo (ASO)
PBMCs were seeded at 5 M/ml into 12-well plate. After 30 min, the
suspending lymphocytes were removed and the remaining mono-
cytes were changed to the M-CSF (10 ng/ml) containing medium.
Media were changed every 2 days, and monocytes were differenti-
ated into macrophages for 7 days. Next, transfection of 100 nM
non-targeting ASO (CGACTATACGCGCAATATGG) or ROCKI ASO
(TATATTTCAACCAGGAGGCAC) was performed using RNAiMAX
(Thermo Fisher Scientific) for 48 h. After stimulation with Pam3 for
additional 8 h, cells were harvested in TRIzol for detection of
ROCKI, MARCKS, and IL-6 expressions.
Repression of ROCKI expression using CRISPR inhibitor (CRISPRi)
For CRISPRi repression of ROCKI, we used the system that was
previously established by Gilbert (Gilbert et al, 2013) with the
following modifications. Briefly, polyclonal THP1 cells expressing
dCas9/KRAB/BFP fusion proteins were generated by lentivirus
transduction. Cells with higher BFP expression were sorted out.
Two sgRNA oligos targeting ROCKI were designed and inserted into
sgRNA expressing vector (lentiGuide-puro, Addgene 52963). Next,
the vectors were packed into lentivirus and delivered into the sorted
THP1- dCas9/KRAB/BFP cells. After 7 days of puromycin selection,
cells were seeded and differentiated into macrophages, and stimu-
lated with Pam3 for 8 h. The expressions of ROCKI, MARCKS, and
IL-6 were then determined using RT–PCR. sgRNA primers are listed
in Table EV2.
RNA extraction and RT–qPCR
RNA was extracted from THP1 cells using TRIzol reagent (Invitro-
gen) according to the manufacturer’s protocol. RNA was treated
with DNase I (Ambion) to remove contaminating DNA, and samples
of ~1 lg of RNA were reverse transcribed using Superscript III or
VILO Mastermix (Invitrogen). qPCR was performed using SYBR
Green mix or SsoAdvanced SYBR Green mix (Bio-Rad). The fold
change in gene expression was calculated by the DDCt method using
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an internal
control. The primers used for qPCR are listed in Table EV2.
Rapid amplification of cDNA ends (RACE)
Total RNA was isolated from LPS-treated THP1 cells and processed
with a Ribo-Zero-rRNA Removal kit to deplete ribosomal RNA
(Epicentre). RACE was performed using a SMARTer RACE kit
(Clontech) according to the user manual. Briefly, ~100 ng of puri-
fied poly(A) RNA was used for each RT reaction to produce
lncRNA cDNA (20 ll), and nested PCRs were performed to amplify
the lncRNA cDNA ends. Primer sequences for nested PCR reac-
tions are listed in Table EV2. RACE PCR products were cloned
using Zero Blunt TOPO cloning kit (Thermo Fisher Scientific) and
then sequenced.
Chromatin isolation by RNA purification (ChIRP)
ROCKI binding to the MARCKS promoter was detected by ChIRP
performed using 30 probes specific for ROCKI. The probes were
designed using the online probe designer version 4.2 from LGC
Biosearch Technologies. Masking level was set at 2, and the mini-
mum spacing length was set at 60 nucleotides. Oligonucleotides
were biotinylated at the 30 end. THP1 cells were incubated in
medium containing 20 ng/ml PMA for 18 h and then treated with or
without 100 ng/ml Pam3 for 8 h. Cells were trypsinized, washed in
medium, and then washed twice with PBS. Cells were fixed in 1%
glutaraldehyde in PBS at room temperature for 10 min and then
quenched with 1/10th volume of 1.25 M glycine for 5 min. Fixed
cells were harvested by centrifuging at 2000 RCF for 5 min and
washed twice with PBS. The cells were then lysed in lysis buffer
(5 mM PIPES pH 8.0, 85 mM KCl, 0.5% NP-40), Dounce-homoge-
nized 10 times on ice, and incubated for 10 min. Cell lysates were
centrifuged at 2,500 g for 5 min at 4°C and the nuclear pellets were
collected and sonicated (15 cycles, 30 s on, 30 s off). Isolated chro-
matin was analyzed for enrichment of ROCKI at the MARCKS
promoter by ChIRP using the method described by Chu et al (2012).
RT–qPCR primers are listed in Table EV2.
In vitro transcription and ROCKI RNA–protein pull-down assay
ROCKI, antisense of ROCKI, or lacZ control was cloned into pBlue-
script KSII downstream of the T7 promoter separately (primers
listed in Table EV2). The vectors were linearized by KpnI digestion,
and 1 lg of linear lacZvectors was transcribed and biotinylated
in vitro using a kit (Epicentre), according to the manufacturer’s
instructions. Biotinylated RNAs were purified, refolded, and incu-
bated with nuclear lysates from THP1-derived macrophages using
the method described previously (Li et al, 2014). Briefly, 2 lg of
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diluted RNA (200 ng/ll) was incubated at 60°C for 10 min and
slowly cooled to 4°C. Nuclear lysates were prepared from 2 × 108
PMA-differentiated THP1-derived macrophages treated with 100 ng/
ml Pam3 for 8 h. Protein concentrations were measured by the DC
assay (Bio-Rad) according to the manufacturer’s instructions. For
the pull-down incubations, nuclear lysates (1 mg of protein) were
precleared with streptavidin beads (Invitrogen) and then incubated
with 2 lg of biotinylated RNA and 40 ll of streptavidin beads for
2 h at 4°C. The beads were collected and washed three times with
buffer C. RNA-associated proteins were eluted and analyzed by
mass spectrometry (Sanford Burnham Prebys Medical Discovery
Institute Core) or by Western blotting, as described below.
Reverse pull-down assays
To confirm that APEX1 binds to ROCKI, nuclear lysates (1 mg
protein per sample) from 1 × 108 THP1-derived macrophages
treated with Pam3 for 8 h were precleared with protein G beads
(NEB) for 2 h at 4°C and then incubated with control rabbit IgG
or anti-APEX1 antibody (4 lg per sample, Novus, NB100-101)
overnight at 4°C. Protein G beads pre-blocked with bovine serum
albumin were added to the samples for 2 h at 4°C, collected by
centrifugation, washed three times with buffer C, and resus-
pended in 1 ml buffer C. RNA was extracted from 900 ll of each
sample using TRIzol and treated with Turbo DNase to remove
contaminating DNA. ROCKI levels were analyzed by RT–qPCR.
The remaining 100 ll of each sample was collected, boiled for
5 min, and subjected to Western blot analysis to detect RNA-
associated APEX1.
Chromatin immunoprecipitation (ChIP)
ChIP was performed using the method described by Deliard et al
(2013) with minor modifications. Briefly, 2 × 107 THP1 macro-
phages were cross-linked with 1% formaldehyde for 10 min at
room temperature and incubated with glycine for 5 min. Cells
were collected by centrifugation, washed twice with PBS, lysed
in lysis buffer, Dounce-homogenized 10 times on ice, and incu-
bated for 10 min. The lysates were centrifuged at 4,000 rpm for
5 min at 4°C, and the nuclear pellets were resuspended in SDS
lysis buffer and sonicated for 15 cycles (30 s on, 30 s off). DNA
concentrations were quantified, and 10 lg of chromatin DNA was
used for each ChIP reaction. ChIP assays were performed with
4 lg of antibody and 40 ll of protein G magnetic beads. The
samples were incubated overnight at 4°C, washed, and eluted.
Bead-bound DNA was reverse cross-linked and purified. RT–qPCR
analysis was performed to detect the presence of two MARCKS
promoter region sequences or an ACTB2 sequence. ACTB2
primers were purchased from Active Motif (71005). The antibod-
ies used in these experiments include a-HDAC1 antibody (Abcam,
ab7028), a-APEX1 (Novus, NB100-116), and a-H3K27ac (Abcam,
ab4726).
Co-immunoprecipitation assay
To determine whether APEX1 and HDAC1 interact, APEX1 was
immunoprecipitated as described for the reverse RNA pull-down
assay. The beads were resuspended in 1 ml buffer C, and 900 ll
was subjected to Western blot analysis of HDAC1 protein in the
immunoprecipitates. The remaining 100 ll of sample was collected
for RT–qPCR analysis of ROCKI.
Western blotting
Protein lysates were separated on 4–20% SDS/PAGE gels and trans-
ferred to PVDF membranes. Western blotting was performed using
Fast Western Blot kits (Thermo Scientific Pierce) with the following
antibodies: mouse anti-FLAG M2 antibody (Sigma, F1804), rabbit
anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Cell
Signaling Technology, 2118), rabbit anti-APEX1 (NOVUS, NB100-
101), mouse anti-HDAC1 (NOVUS, NB100-56340SS), rabbit anti-
H3K27ac (Cell Signaling Technology, 9733S), and mouse anti-
vimentin (Abcam, ab8978).
Calcium flux assay
To detect changes in intracellular Ca2+ concentration in THP1-
derived macrophages, 4 × 105 cells expressing control, MARCKS, or
ROCKI shRNA were preincubated with the Ca2+ indicator Fluo-4
(Thermo Fisher, F14201) at 6 lM for 30 min, washed with Hanks’
Balanced Salt Solution, and aliquoted into a 96-well plate at
4 × 104/well. Fluorescence signals were detected before and every
30 s after stimulation with PMA (50 ng/ml) and Pam3 (500 ng/ml).
The maximal [Ca2+] response was determined by adding 0.1%
Triton X-100 to the cells at the end of the detection period. The
change in fluorescence was normalized to the maximal fluorescence
signal and is expressed as DF/Fmax.
MARCKS and ROCKI QTL analysis
Publicly available whole blood eQTL summary statistics were
downloaded from the Genotype-Tissue Expression (Consortium
et al, 2017) project v7 release (Consortium et al, 2017). We
extracted all variants that were tested for association with ROCKI
and MARCKS expression for further analysis. We also downloaded
CD14+ monocyte QTL summary statistic datasets for gene expres-
sion, H3K4me1, and H3K27ac from the BLUEPRINT epigenome
project (Chen et al, 2016). The monocyte eQTL dataset could not be
used in these analyses because it used an earlier release (GENCODE
v15) for transcript annotation and ROCKI was not among the genes
tested in this study. We extracted QTLs for H3K27ac and H3K4me1
signal in a genomic region around MARCKS and ROCKI.
For each dataset, we calculated Bayes factors for each variant in
a 1 MB window around the signal following the approach of Wake-
field (Wakefield, 2009). We then used a Bayesian co-localization
method to determine whether the whole blood eQTL association for
ROCKI and monocyte H3K27ac QTL association upstream of the
ROCKI promoter and eQTL association for MARCKS showed
evidence of a shared causal variant (Giambartolomei et al, 2014).
We considered signals with a shared probability (Pshared) > 0.9.
We then performed fine-mapping to determine the causal vari-
ant for the shared signal using ROCKI eQTL and H3K27ac QTL
data. For each variant in a 1 MB window around the signal and in
common to both datasets, we multiplied Bayes factors for each
signal and calculated a posterior probability of association (PPA)
for each variant as the Bayes factor divided by the sum of Bayes
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factors across all variants. We then intersected candidate casual
variants with DNase I hypersensitivity sites (DHS) and transcrip-
tion factor ChIP-seq sites from the ENCODE project (Maurano
et al, 2012).
UK Biobank GWAS data analysis for phenotypic associations
Publicly available UK Biobank GWAS summary statistics for 2,419
phenotypes were downloaded (https://sites.google.com/broadinsti
tute.org/ukbbgwasresults). Phenotypes that did not appear to be
related to diseases or disease treatments were removed, and we
then extracted summary statistics for the most significantly associ-
ated ROCKI eQTL variant (rs9387181). For each phenotype, we
aligned summary results to the ROCKI-reducing allele of rs9387181.
We then categorized 1,464 disease- and medication-related pheno-
types into 22 groups, removing phenotypes that did not fit in a clear
group. We then plotted the signed test statistic of phenotypes within
each group, and the average signed test statistic within each group.
Statistical analysis
Differences between groups were analyzed using Student’s t-test
(paired, two-sided). Data are presented as the mean  standard
deviation (SD). N = 3. Differences were considered statistically
significant when P < 0.05.
Data availability
Data generated in this study have been submitted to the NCBI Gene
Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/)
under accession numbers GSE109084 (related to Fig 1) and
GSE108680 (related to Fig 6).
Expanded View for this article is available online.
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